FDA Inspection 1037070 — Martin Ekwealor Pharmaceuticals, Inc.
The FDA completed an inspection of Martin Ekwealor Pharmaceuticals, Inc. on Dec 13, 2017 in Economy, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 13, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Economy, IN (United States)